Fora Capital, LLC Ab Cellera Biologics Inc. Transaction History
Fora Capital, LLC
- $903 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding ABCL
# of Institutions
151Shares Held
121MCall Options Held
156KPut Options Held
346K-
Baker Bros. Advisors LP New York, NY27.5MShares$55.6 Million0.73% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL15.7MShares$31.7 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$27 Million0.01% of portfolio
-
Baillie Gifford & CO11.2MShares$22.6 Million0.02% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$21.5 Million0.03% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $576M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...